The SELECT study, or Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity, is one of the largest cardiovascular outcome studies in the field of obesity research
By handling the intricate semaglutide prior authorization process on your behalf, Klinic eliminates the bureaucratic complexities so you can focus on your journey to health
Some insurance plans may cover GLP-1 medications, and we assist with benefit checks and prior authorizations
A cross-sectional observational study was conducted to consider the link of obesity with vitamin D and the link of obesity with Trimethylamine-N-oxide (TMAO), and if these associations could be influenced by non-alcoholic fatty liver disease (NAFLD)
There are multifaceted challenges in the injectable sector that we strive to address, says Carolin Gruber, Product and Service Manager Primary Packaging and Devices, Vetter